CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)	Preferred Stock [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	Accumulated Deficit [Member]	Total Precipio, Inc. [Member]	Noncontrolling Interest in Joint Venture [Member]	Total
Balance at beginning of period at Dec. 31, 2020		$ 176,000	$ 85,523,000	$ (71,564,000)	$ 14,135,000	$ 27,000	$ 14,162,000
Balance at beginning of period (in shares) at Dec. 31, 2020	47	17,576,916
Increase (Decrease) in Stockholders' Equity
Net loss				(6,325,000)	(6,325,000)	10,000	(6,315,000)
Issuance of common stock in connection with purchase agreements		$ 5,000	1,255,000		1,260,000		1,260,000
Issuance of common stock in connection with purchase agreements (in shares)		500,000
Issuance of common stock in connection with at the market offering, net of issuance costs		$ 45,000	14,902,000		14,947,000		14,947,000
Issuance of common stock in connection with at the market offering, net of issuance costs (in shares)		4,501,000
Proceeds upon issuance of common stock from exercise of warrants		$ 1,000	399,000		400,000		400,000
Proceeds upon issuance of common stock from exercise of warrants (in shares)		74,000
Proceeds upon issuance of common stock from exercise of stock options			3,000		3,000		3,000
Proceeds upon issuance of common stock from exercise of stock options (in shares)		1,229
Issuance of common stock for consulting services		$ 200,000	150,000		150,000		150,000
Issuance of common stock for consulting services (in shares)		55,147
Stock-based compensation			1,310,000		1,310,000		1,310,000
Balance at end of period at Sep. 30, 2021		$ 227,000	103,542,000	(77,889,000)	25,880,000	37,000	25,917,000
Balance at end of period (in shares) at Sep. 30, 2021	47	22,708,292
Balance at beginning of period at Jun. 30, 2021		$ 227,000	103,029,000	(76,029,000)	27,227,000	31,000	27,258,000
Balance at beginning of period (in shares) at Jun. 30, 2021	47	22,707,063
Increase (Decrease) in Stockholders' Equity
Net loss				(1,860,000)	(1,860,000)	6,000	(1,854,000)
Proceeds upon issuance of common stock from exercise of warrants			3,000		3,000		$ 3,000
Proceeds upon issuance of common stock from exercise of warrants (in shares)		1,229					0
Proceeds upon issuance of common stock from exercise of stock options							$ 3,000
Stock-based compensation			510,000		510,000		510,000
Balance at end of period at Sep. 30, 2021		$ 227,000	103,542,000	(77,889,000)	25,880,000	37,000	25,917,000
Balance at end of period (in shares) at Sep. 30, 2021	47	22,708,292
Balance at beginning of period at Dec. 31, 2021		$ 227,000	104,431,000	(80,094,000)	24,564,000	40,000	24,604,000
Balance at beginning of period (in shares) at Dec. 31, 2021	47	22,708,442
Increase (Decrease) in Stockholders' Equity
Net loss				(9,913,000)	(9,913,000)	18,000	(9,895,000)
Issuance of common stock in connection with at the market offering, net of issuance costs		$ 1,000	128,000		129,000		129,000
Issuance of common stock in connection with at the market offering, net of issuance costs (in shares)		85,023
Proceeds upon issuance of common stock from exercise of warrants			11,000		11,000		11,000
Proceeds upon issuance of common stock from exercise of warrants (in shares)		26,795
Stock-based compensation			3,405,000		3,405,000		3,405,000
Balance at end of period at Sep. 30, 2022		$ 228,000	107,975,000	(90,007,000)	18,196,000	58,000	18,254,000
Balance at end of period (in shares) at Sep. 30, 2022	47	22,820,260
Balance at beginning of period at Jun. 30, 2022		$ 227,000	107,114,000	(86,828,000)	20,513,000	52,000	20,565,000
Balance at beginning of period (in shares) at Jun. 30, 2022	47	22,708,708
Increase (Decrease) in Stockholders' Equity
Net loss				(3,179,000)	(3,179,000)	6,000	(3,173,000)
Issuance of common stock in connection with at the market offering, net of issuance costs		$ 1,000	128,000		129,000		129,000
Issuance of common stock in connection with at the market offering, net of issuance costs (in shares)		85,023
Proceeds upon issuance of common stock from exercise of warrants			11,000		11,000		11,000
Proceeds upon issuance of common stock from exercise of warrants (in shares)		26,529
Stock-based compensation			722,000		722,000		722,000
Balance at end of period at Sep. 30, 2022		$ 228,000	$ 107,975,000	$ (90,007,000)	$ 18,196,000	$ 58,000	$ 18,254,000
Balance at end of period (in shares) at Sep. 30, 2022	47	22,820,260